1887

Abstract

The oral cavity is one of the largest reservoirs of microorganisms and many pathogenic bacteria have been shown to be associated with the aetiology of oral cancers.

Owing to the complexity of oral microbial communities and their unclear relationship with oral cancer, identification of specific bacteria which contribute to oral cancer is a key imperative.

To compare and investigate the variations in the composition of the bacterial microbiome and its functions between patients with oral tumorous lesions and healthy subjects.

Twenty-seven samples from individuals with oral tumours (five oral benign tumours and 22 oral squamous cell carcinomas) and 15 samples from healthy subjects were collected. Genomic DNA was extracted and the V3–V5 region of the 16S rRNA gene was sequenced. Subsequently, bioinformatic assessment was conducted using QIIME2, PICRUSt and linear discriminant analysis effect size analyses (LEfSe).

The oral microbiota was composed mainly of the phyla (31.76 %, 35.00 %), (30.13 %, 25.13 %) and (23.92 %, 17.07 %) in tumorous and healthy individuals, respectively. , , , , , , , , and were the most abundant genera. Alpha diversity in the tumour group was significantly greater than that in the healthy group (<0.05). Differential analysis of microbes between groups demonstrated a significantly higher number of , , , , , , , , and in healthy controls compared with the tumour group. However, the genera , , , , , , , , , and were significantly higher in the tumour group. Pathways related to cancers, cell motility, environmental adaptation, metabolism and signal transduction were enhanced in the tumour group, while functions associated with immune system diseases, replication, repair and translation were significantly enhanced in the healthy group.

Variations in the oral microbiota and its functions showed a correlation with oral tumours. The tumour group showed an increased abundance of some multi-drug-resistant and periodontitis-related pathogens. The significantly altered microbiotas may serve as potential biomarkers or inform combination therapy for oral tumours.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001568
2022-08-03
2024-04-26
Loading full text...

Full text loading...

/deliver/fulltext/jmm/71/8/jmm001568.html?itemId=/content/journal/jmm/10.1099/jmm.0.001568&mimeType=html&fmt=ahah

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68:394–424 [View Article] [PubMed]
    [Google Scholar]
  2. Kademani D. Oral cancer. Mayo Clin Proc 2007; 82:878–887 [View Article] [PubMed]
    [Google Scholar]
  3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020; 70:7–30 [View Article] [PubMed]
    [Google Scholar]
  4. Huber MA, Tantiwongkosi B. Oral and oropharyngeal cancer. Med Clin North Am 2014; 98:1299–1321 [View Article] [PubMed]
    [Google Scholar]
  5. Fu J-Y, Wu C-X, Zhang C-P, Gao J, Luo J-F et al. Oral cancer incidence in Shanghai ---- a temporal trend analysis from 2003 to 2012. BMC Cancer 2018; 18:686 [View Article] [PubMed]
    [Google Scholar]
  6. Lei L, Zheng R, Peng K, Si L, Peng J et al. Incidence and mortality of oral and oropharyngeal cancer in China, 2015. Chin J Cancer Res 2020; 32:1–9 [View Article] [PubMed]
    [Google Scholar]
  7. Lin X, Wu X, Gomaa A, Chen J, Wu L et al. Analysis of risk factors for multiple primary oral squamous cell carcinoma: a cohort study. Clin Oral Investig 2020; 24:3147–3155 [View Article] [PubMed]
    [Google Scholar]
  8. Guha N, Warnakulasuriya S, Vlaanderen J, Straif K. Betel quid chewing and the risk of oral and oropharyngeal cancers: a meta-analysis with implications for cancer control. Int J Cancer 2014; 135:1433–1443 [View Article] [PubMed]
    [Google Scholar]
  9. Hung L-C, Kung P-T, Lung C-H, Tsai M-H, Liu S-A et al. Assessment of the risk of oral cancer Incidence in a high-risk population and establishment of a predictive model for oral cancer incidence using a population-based cohort in Taiwan. Int J Environ Res Public Health 2020; 17:E665 [View Article] [PubMed]
    [Google Scholar]
  10. Bai X-X, Zhang J, Wei L. Analysis of primary oral and oropharyngeal squamous cell carcinoma in inhabitants of Beijing, China-a 10-year continuous single-center study. BMC Oral Health 2020; 20:208 [View Article] [PubMed]
    [Google Scholar]
  11. Kim SS, Ruiz VE, Carroll JD, Moss SF. Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Lett 2011; 305:228–238 [View Article] [PubMed]
    [Google Scholar]
  12. Rochford R, Korir A, Newton R. Viral-associated malignancies in Africa: are viruses “infectious traces” or “dominant drivers”?. Curr Opin Virol 2016; 20:28–33 [View Article] [PubMed]
    [Google Scholar]
  13. Flavahan WA, Gaskell E, Bernstein BE. Epigenetic plasticity and the hallmarks of cancer. Science 2017; 357:eaal2380 [View Article] [PubMed]
    [Google Scholar]
  14. Doorakkers E, Lagergren J, Engstrand L, Brusselaers N. Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population. Gut 2018; 67:2092–2096 [View Article] [PubMed]
    [Google Scholar]
  15. Baker JL, Bor B, Agnello M, Shi W, He X. Ecology of the oral microbiome: beyond bacteria. Trends Microbiol 2017; 25:362–374 [View Article] [PubMed]
    [Google Scholar]
  16. Yang C-Y, Yeh Y-M, Yu H-Y, Chin C-Y, Hsu C-W et al. Oral microbiota community dynamics associated with oral squamous cell carcinoma staging. Front Microbiol 2018; 9:862 [View Article]
    [Google Scholar]
  17. Bolz J, Dosá E, Schubert J, Eckert AW. Bacterial colonization of microbial biofilms in oral squamous cell carcinoma. Clin Oral Investig 2014; 18:409–414 [View Article]
    [Google Scholar]
  18. Al-Hebshi NN, Nasher AT, Maryoud MY, Homeida HE, Chen T et al. Inflammatory bacteriome featuring Fusobacterium nucleatum and Pseudomonas aeruginosa identified in association with oral squamous cell carcinoma. Sci Rep 2017; 7:1834 [View Article]
    [Google Scholar]
  19. Chen MY, Chen JW, Wu LW, Huang KC, Chen JY et al. Carcinogenesis of male oral submucous fibrosis alters salivary microbiomes. J Dent Res 2021; 100:397–405 [View Article]
    [Google Scholar]
  20. Lee W-H, Chen H-M, Yang S-F, Liang C, Peng C-Y et al. Bacterial alterations in salivary microbiota and their association in oral cancer. Sci Rep 2017; 7:16540 [View Article]
    [Google Scholar]
  21. Schmidt BL, Kuczynski J, Bhattacharya A, Huey B, Corby PM et al. Changes in abundance of oral microbiota associated with oral cancer. PLoS One 2014; 9:e98741 [View Article] [PubMed]
    [Google Scholar]
  22. Mai X, Genco RJ, LaMonte MJ, Hovey KM, Freudenheim JL et al. Periodontal pathogens and risk of incident cancer in postmenopausal females: the buffalo osteoperio study. J Periodontol 2016; 87:257–267 [View Article] [PubMed]
    [Google Scholar]
  23. Banerjee S, Tian T, Wei Z, Peck KN, Shih N et al. Microbial signatures associated with oropharyngeal and oral squamous cell carcinomas. Sci Rep 2017; 7:4036 [View Article] [PubMed]
    [Google Scholar]
  24. Komiya Y, Shimomura Y, Higurashi T, Sugi Y, Arimoto J et al. Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity. Gut 2019; 68:1335–1337 [View Article] [PubMed]
    [Google Scholar]
  25. Gao S, Li S, Ma Z, Liang S, Shan T et al. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infect Agent Cancer 2016; 11:3 [View Article] [PubMed]
    [Google Scholar]
  26. Gao S-G, Yang J-Q, Ma Z-K, Yuan X, Zhao C et al. Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma. BMC Cancer 2018; 18:17 [View Article]
    [Google Scholar]
  27. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012; 22:299–306 [View Article]
    [Google Scholar]
  28. Vartoukian SR, Palmer RM, Wade WG. Strategies for culture of “unculturable” bacteria. FEMS Microbiol Lett 2010; 309:1–7 [View Article]
    [Google Scholar]
  29. Vo A-TE, Jedlicka JA. Protocols for metagenomic DNA extraction and Illumina amplicon library preparation for faecal and swab samples. Mol Ecol Resour 2014; 14:1183–1197 [View Article]
    [Google Scholar]
  30. Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 2019; 37:852–857 [View Article]
    [Google Scholar]
  31. Kaehler BD, Bokulich NA, McDonald D, Knight R, Caporaso JG et al. Species abundance information improves sequence taxonomy classification accuracy. Nat Commun 2019; 10:4643 [View Article] [PubMed]
    [Google Scholar]
  32. Bokulich NA, Kaehler BD, Rideout JR, Dillon M, Bolyen E et al. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin. Microbiome 2018; 6:90 [View Article] [PubMed]
    [Google Scholar]
  33. Ye SH, Siddle KJ, Park DJ, Sabeti PC. Benchmarking metagenomics tools for taxonomic classification. Cell 2019; 178:779–794 [View Article] [PubMed]
    [Google Scholar]
  34. Langille MGI, Zaneveld J, Caporaso JG, McDonald D, Knights D et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 2013; 31:814–821 [View Article] [PubMed]
    [Google Scholar]
  35. Sun J, Tang Q, Yu S, Xie M, Xie Y et al. Role of the oral microbiota in cancer evolution and progression. Cancer Med 2020; 9:6306–6321 [View Article] [PubMed]
    [Google Scholar]
  36. Deo PN, Deshmukh R. Oral microbiome: unveiling the fundamentals. J Oral Maxillofac Pathol 2019; 23:122–128 [View Article]
    [Google Scholar]
  37. Chattopadhyay I, Verma M, Panda M. Role of oral microbiome signatures in diagnosis and prognosis of oral cancer. Technol Cancer Res Treat 2019; 18:1533033819867354 [View Article]
    [Google Scholar]
  38. Yamashita Y, Takeshita T. The oral microbiome and human health. J Oral Sci 2017; 59:201–206 [View Article]
    [Google Scholar]
  39. Guerrero-Preston R, Godoy-Vitorino F, Jedlicka A, Rodríguez-Hilario A, González H et al. 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment. Oncotarget 2016; 7:51320–51334 [View Article]
    [Google Scholar]
  40. Zhao H, Chu M, Huang Z, Yang X, Ran S et al. Variations in oral microbiota associated with oral cancer. Sci Rep 2017; 7:11773 [View Article]
    [Google Scholar]
  41. Wang L, Yin G, Guo Y, Zhao Y, Zhao M et al. Variations in oral microbiota composition are associated with a risk of throat cancer. Front Cell Infect Microbiol 2019; 9:205 [View Article] [PubMed]
    [Google Scholar]
  42. Al-Hebshi NN, Nasher AT, Idris AM, Chen T. Robust species taxonomy assignment algorithm for 16S rRNA NGS reads: application to oral carcinoma samples. J Oral Microbiol 2015; 7:28934 [View Article] [PubMed]
    [Google Scholar]
  43. Sun DL, Jiang X, Wu QL, Zhou NY. Intragenomic heterogeneity of 16S rRNA genes causes overestimation of prokaryotic diversity. Appl Environ Microbiol 2013; 79:5962–5969 [View Article] [PubMed]
    [Google Scholar]
  44. Li Y, Tan X, Zhao X, Xu Z, Dai W et al. Composition and function of oral microbiota between gingival squamous cell carcinoma and periodontitis. Oral Oncol 2020; 107:104710 [View Article] [PubMed]
    [Google Scholar]
  45. Takeshita T, Kageyama S, Furuta M, Tsuboi H, Takeuchi K et al. Bacterial diversity in saliva and oral health-related conditions: the Hisayama Study. Sci Rep 2016; 6:22164 [View Article] [PubMed]
    [Google Scholar]
  46. Sims TT, El Alam MB, Karpinets TV, Dorta-Estremera S, Hegde VL et al. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation. Commun Biol 2021; 4:237 [View Article] [PubMed]
    [Google Scholar]
  47. Heshiki Y, Vazquez-Uribe R, Li J, Ni Y, Quainoo S et al. Predictable modulation of cancer treatment outcomes by the gut microbiota. Microbiome 2020; 8:28 [View Article] [PubMed]
    [Google Scholar]
  48. Bhushan B, Yadav AP, Singh SB, Ganju L. Diversity and functional analysis of salivary microflora of Indian Antarctic expeditionaries. J Oral Microbiol 2019; 11:1581513 [View Article] [PubMed]
    [Google Scholar]
  49. Zaura E, Keijser BJF, Huse SM, Crielaard W. Defining the healthy “core microbiome” of oral microbial communities. BMC Microbiol 2009; 9:259 [View Article] [PubMed]
    [Google Scholar]
  50. Abranches J, Zeng L, Kajfasz JK, Palmer SR, Chakraborty B et al. Biology of oral Streptococci. Microbiol Spectr 2018; 6: [View Article] [PubMed]
    [Google Scholar]
  51. Tagaino R, Washio J, Abiko Y, Tanda N, Sasaki K et al. Metabolic property of acetaldehyde production from ethanol and glucose by oral Streptococcus and Neisseria. Sci Rep 2019; 9:10446 [View Article]
    [Google Scholar]
  52. Singh NP, Khan A. Acetaldehyde: genotoxicity and cytotoxicity in human lymphocytes. Mutat Res 1995; 337:9–17 [View Article] [PubMed]
    [Google Scholar]
  53. Parida S, Sharma D. The power of small changes: comprehensive analyses of microbial dysbiosis in breast cancer. Biochim Biophys Acta Rev Cancer 2019; 1871:392–405 [View Article] [PubMed]
    [Google Scholar]
  54. Lawani-Luwaji EU, Alade T. Sphingomonadaceae: protective against breast cancer?. Bull Natl Res Cent 2020; 44:191 [View Article]
    [Google Scholar]
  55. Velusamy SK, Sampathkumar V, Ramasubbu N, Paster BJ, Fine DH. Aggregatibacter actinomycetemcomitans colonization and persistence in a primate model. Proc Natl Acad Sci U S A 2019; 116:22307–22313 [View Article] [PubMed]
    [Google Scholar]
  56. Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D et al. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2009; 18:2406–2412 [View Article]
    [Google Scholar]
  57. Teshima R, Hanada K, Akada J, Kawano K, Yamaoka Y. Aggregatibacter actinomycetemcomitans infection causes DNA double-strand breaks in host cells. Genes Cells 2018; 23:264–273 [View Article]
    [Google Scholar]
  58. Sampathkumar V, Velusamy SK, Godboley D, Fine DH. Increased leukotoxin production: characterization of 100 base pairs within the 530 base pair leukotoxin promoter region of Aggregatibacter actinomycetemcomitans. Sci Rep 2017; 7:1887 [View Article]
    [Google Scholar]
  59. Mukherjee A, Jantsch V, Khan R, Hartung W, Fischer R et al. Rheumatoid arthritis-associated autoimmunity due to Aggregatibacter actinomycetemcomitans and its resolution with antibiotic therapy. Front Immunol 2018; 9:2352 [View Article]
    [Google Scholar]
  60. Turner E, Hastie T, Sundaresan PD. Pulmonary infection masquerades as malignancy in a patient with periodontitis. BMJ Case Rep 2021; 14: [View Article]
    [Google Scholar]
  61. Matzumura-Kuan M, Jennings J. Aggregatibacter actinomycetemcomitans infection mimicking lung cancer: a case report. Scand J Infect Dis 2014; 46:669–672 [View Article]
    [Google Scholar]
  62. Fan X, Alekseyenko AV, Wu J, Peters BA, Jacobs EJ et al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut 2018; 67:120–127 [View Article]
    [Google Scholar]
  63. Kawasaki M, Ikeda Y, Ikeda E, Takahashi M, Tanaka D et al. Oral infectious bacteria in dental plaque and saliva as risk factors in patients with esophageal cancer. Cancer 2021; 127:512–519 [View Article]
    [Google Scholar]
  64. Belusic-Gobic M, Zubovic A, Predrijevac A, Harmicar D, Cerovic R et al. Microbiology of wound infection after oral cancer surgery. J Craniomaxillofac Surg 2020; 48:700–705 [View Article]
    [Google Scholar]
  65. Perera M, Al-Hebshi NN, Perera I, Ipe D, Ulett GC et al. Inflammatory bacteriome and oral squamous cell carcinoma. J Dent Res 2018; 97:725–732 [View Article]
    [Google Scholar]
  66. Ibrahim IM, Puthiyaveetil S, Allen JF. A Two-component regulatory system in transcriptional control of photosystem stoichiometry: redox-dependent and sodium ion-dependent phosphoryl transfer from cyanobacterial histidine kinase hik2 to response regulators Rre1 and RppA. Front Plant Sci 2016; 7:137 [View Article] [PubMed]
    [Google Scholar]
  67. Williams SM, Chen YT, Andermann TM, Carter JE, McGee DJ et al. Helicobacter pylori chemotaxis modulates inflammation and bacterium-gastric epithelium interactions in infected mice. Infect Immun 2007; 75:3747–3757 [View Article] [PubMed]
    [Google Scholar]
  68. Wang J, Qi J, Zhao H, He S, Zhang Y et al. Metagenomic sequencing reveals microbiota and its functional potential associated with periodontal disease. Sci Rep 2013; 3:1843 [View Article] [PubMed]
    [Google Scholar]
  69. Duong MT-Q, Qin Y, You S-H, Min J-J. Bacteria-cancer interactions: bacteria-based cancer therapy. Exp Mol Med 2019; 51:1–15 [View Article] [PubMed]
    [Google Scholar]
  70. Sun Z, Xiong C, Teh SW, Lim JCW, Kumar S et al. Mechanisms of oral bacterial virulence factors in pancreatic cancer. Front Cell Infect Microbiol 2019; 9:412 [View Article] [PubMed]
    [Google Scholar]
  71. Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability--an evolving hallmark of cancer. Nat Rev Mol Cell Biol 2010; 11:220–228 [View Article] [PubMed]
    [Google Scholar]
  72. Hutton CA, Perugini MA, Gerrard JA. Inhibition of lysine biosynthesis: an evolving antibiotic strategy. Mol Biosyst 2007; 3:458–465 [View Article] [PubMed]
    [Google Scholar]
  73. Ennis MA, Ong A-J, Lim K, Ball RO, Pencharz PB et al. Dietary aromatic amino acid requirements during early and late gestation in healthy pregnant women. J Nutr 2020; 150:3224–3230 [View Article] [PubMed]
    [Google Scholar]
  74. Sitkin SI, Tkachenko EI, Vakhitov TY. Metabolic dysbiosis of the gut microbiota and its biomarkers. Eksp Klin Gastroenterol 2016; 12:6–29 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001568
Loading
/content/journal/jmm/10.1099/jmm.0.001568
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error